Condition
Cervical Cancers clinical trials and research
Research outlook What's coming for Cervical cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 13 Cervical Cancers clinical trials that are recruiting, at sites in 6 countries (most in China (7), United States (3), Cameroon (1)). By phase: Phase 2 (5), Phase 1 (1), Phase 1/2 (1). The most active sponsors are Obstetrics & Gynecology Hospital of Fudan University (2), Cancer Institute and Hospital, Chinese Academy of Medical Sciences (2). There are also 6 NIH-funded research projects on Cervical Cancers, with $3.1 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 13Clinical trials
- 6NIH research projects
- 6Countries
Newest Cervical Cancers clinical trials
All recruiting trials (13)
-
Moderately hypofractionated radiotherapy after hysterectomy for cervical cancer
This study tests whether a shorter, moderately intensified radiotherapy course after surgery is safe and effective for patients with cervical cancer.
-
Ivonescimab with paclitaxel and cisplatin before type A hysterectomy for Stage IB2/IIA1 (2–4 cm) cervical cancer
This trial will test whether adding ivonescimab to paclitaxel and cisplatin before surgery helps women with 2–4 cm (Stage IB2 or IIA1) cervical cancer shrink tumors so they can have a less radical (type A) hysterectomy.
-
3- vs 4-fraction high-dose-rate brachytherapy for cervical cancer
This will test whether a three-fraction high-dose-rate brachytherapy schedule works as well as the standard four-fraction schedule for adults with locally advanced cervical cancer.
-
Neoadjuvant immunochemotherapy for locally advanced cervical cancer
This trial will test whether giving paclitaxel and carboplatin together with a PD‑1/PD‑L1 immune checkpoint inhibitor before definitive treatment helps shrink tumors in patients with locally advanced cervical cancer (FIGO IB3–IIB) with tumors larger than 4 cm.
-
IDOV-Immune for advanced solid tumors
This trial will try a single IV infusion of an engineered oncolytic vaccinia virus called IDOV-Immune in adults with advanced solid tumors that no longer respond to standard treatments.
-
Combination of Iparomlimab and Tuvonralimab with Chemotherapy for Cervical Cancer
This study is testing whether combining two new immune treatments with standard chemotherapy can help women with locally advanced cervical cancer respond better to treatment before surgery.
-
Minimally invasive surgery for recurrent cervical or vaginal cancer
This study is testing a less invasive surgery for patients with recurring cervical or vaginal cancer to see if it can safely remove the cancer and improve their chances of staying cancer-free for three years.
-
Home screening options for cervical cancer
This study is testing if home screening methods for cervical cancer, like using vaginal swabs and urine tests, are as effective as traditional clinic visits to help more people get screened.
-
Validation of a low-cost cervical cancer screening test
This study is testing a new, low-cost cervical cancer screening tool to see if it works as well as traditional methods for women in El Salvador.
-
Testing XNW28012 in patients with advanced solid tumors who have not responded to standard treatments
This study is testing a new treatment called XNW28012 in patients with advanced solid tumors who haven't had success with regular cancer therapies to see if it can help them.
-
Combining Serplulimab with Chemoradiotherapy for High-Risk Postoperative Cervical Cancer
This study is testing if adding the immunotherapy drug Serplulimab to standard chemoradiotherapy can help women with high-risk cervical cancer feel better after surgery.
-
Using Misoprostol to Prevent Cervical Cancer
This study is testing if the medication Misoprostol can help prevent cervical cancer in women who are being screened for the disease.
-
Effects of immunonutrition on patients with advanced cervical cancer
This study is testing if a special nutrition therapy can help people with advanced cervical cancer feel better and handle their treatment side effects while they are receiving chemotherapy and radiation.
NIH-funded research (6)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Targeting tumor Lactobacillus iners to help cervical cancer patients
This grant seeks to understand how a specific bacteria, Lactobacillus iners, in cervical tumors affects treatment and outcomes, with the goal of improving therapy for women with cervical cancer.
-
Connecting communities and clinics to increase early breast and cervical cancer screening in Kenya
This project tries two community-plus-clinic programs to help women in Kenya get breast and cervical cancer screening and follow-up care.
-
Boosting early breast and cervical cancer screening in Kenyan communities
This project tests two combined community outreach and clinic-support programs to help women in Kenya get screened for breast and cervical cancer and receive timely follow-up.
-
Understanding bacteria in cervical cancer to improve treatment
This project looks at a specific bacteria found in cervical tumors to find new ways to make treatments work better for women with cervical cancer.
-
Improving early detection of breast and cervical cancers in Kenya
This study is working to help women in Kenya get better access to breast and cervical cancer screenings by connecting community resources and providing education, so they feel more informed and motivated to take care of their health.
-
Improving cervical cancer outcomes by targeting specific bacteria
This study is looking at how a certain bacteria called Lactobacillus iners, found in cervical tumors, might make cervical cancer harder to treat, and it hopes to find new ways to help women with advanced cervical cancer live longer and healthier lives.
Related topics
Quick answers
How many Cervical Cancers clinical trials are recruiting right now?
13, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in China (7 trials), United States (3 trials), Cameroon (1 trial), Australia (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 5, Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.